Dose: 9.285 mg/kg
Single Dose: 9.3 (9.285)
Frequency: 8 hourly
Route: PO
Instructions: -

Dose: should not be used under 12 years
Single Dose:
Frequency:
Route:
Instructions:

co-codamol is the derivative of Co-Proxamol. It is of Synthetic origin and belongs to opaids/analgesic. It belongs to Cyclo-oxygenase inhibitor pharmacological group on the basis of mechanism of action and also classified in Analgesics and Anti-inflammatory Agents pharmacological group.The Molecular Weight of Co-Proxamol is 299.00.

Co-Proxamol is contraindicated in conditions like Alcohol dependence,Pregnancy,Hypersensitivity to any component of product.

The severe or irreversible adverse effects of Co-Proxamol, which give rise to further complications include Liver damage, Coma, Blood disorders, stomach pain, clammy stin, low blood pressure, slow heart beat, inflamation of pancreas, blood disorders, slow brathing rate, inflamation if pancreas.Co-Proxamol produces potentially life-threatening effects which include Hypotension, Alcoholic liver disease, gaulluadden disease, hypothyroidism. which are responsible for the discontinuation of Co-Proxamol therapy.The symptomatic adverse reactions produced by Co-Proxamol are more or less tolerable and if they become severe, they can be treated symptomatically, these include Weakness, Dizziness, Headache, Nausea, Vomiting, Constipation, Abdominal pain, Rashes, Jaundice, Sedation, Hallucination, Light headedness, Dysphoria, Euphoria, Vision disturbances, dizziness.

Co-Proxamol is primarily indicated in conditions like Mild to moderate pain.

No data regarding the interactions of Co-Proxamol was found.

Drug should not be given to Pregnant Mothers, patients suffering from Kidney dysfunction, patients suffering from Liver Malfunction, and Geriatrics.If prescribing authority justifies the benefits of the drug against the possible damages he/she should reevaluate them and consult the reference material and previous studies.

Co-proxamol should be used with caution in patients with hepatic or renal impairment since higher serum concentrations or delayed elimination may occur. Patients should be advised not to exceed the recommended dose and to avoid alcohol.